While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The measure would seem a premptive strike at a growing industry. No food engineered to include vaccines are approved for use ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...

Afrigen Biologics has secured a $6.2m grant from CEPI to develop the first mRNA-based vaccine against Rift Valley fever.

On March 11 th 2020, the World Health Organization (WHO) declared that COVID-19 was a global pandemic. In the fight against COVID-19, two FDA-approved mRNA vaccines were developed by Pfizer/BioNTech ...

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As clinical trials advance, Ben Hargreaves finds the technology is poised to ...

Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...

President Donald Trump announced a $500billion investment for private companies to develop artificial intelligence tools to ...

Recently, researchers at Afrigen Biologics and Vaccines in Cape Town, working with the WHO’s technology-transfer hub, announced that they produced their own mRNA vaccine candidate. Having a ...